Both ADCY7 and PECAM1 were up-regulated in AML, and patients with high ADCY7 and PECAM1 expression levels were both associated with poorer overall survival (Figure 1B–1CB, 1H–1IH). This evidence concerns the gene PECAM1 and acute myeloid leukemia.